Log in to save to my catalogue

Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in pre...

Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in pre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11713389

Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in predicting conversion to mild cognitive impairment

About this item

Full title

Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in predicting conversion to mild cognitive impairment

Publisher

Hoboken: John Wiley and Sons Inc

Journal title

Alzheimer's & dementia, 2024-12, Vol.20 (S9), p.n/a

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley and Sons Inc

Subjects

More information

Scope and Contents

Contents

Background
We examined whether brain amyloid PET, hippocampal volume, or plasma biomarkers are better predictors of conversion to mild cognitive impairment (MCI).
Method
In the Baltimore Longitudinal Study of Aging (BLSA), plasma Aß42, Aß40, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) concentrations were mea...

Alternative Titles

Full title

Comparison of amyloid positron emission tomography, hippocampal volume, and plasma biomarkers in predicting conversion to mild cognitive impairment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11713389

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11713389

Other Identifiers

ISSN

1552-5260

E-ISSN

1552-5279

DOI

10.1002/alz.093667

How to access this item